Advanced Cell Together With Geron Start to Reveal Amazing Potential of Stem Cell Therapy – ACTC, SAVW, EVCA, EMIS

Advanced Cell Technology, Inc. (OTC:ACTC) added 6.12% to $0.0013 with the total traded volume of 7.76 million shares.

The case for amplified stem cell funding is increasing by the day as the potentially lifesaving influences of regenerative medicine continue to be unlocked. Scientists claim that stem cells are the future of healthcare, and that regenerative medicine is one of the most misinterpreted fields in biotechnology. The Bedford Report inspects the view for companies in the Biotechnology Industry and offers investment research on Advanced Cell Technology and Geron Corporation.

SavWatt USA Inc (OTC:SAVW) gained 30.00% to $0.0013 with the total traded volume of 46.64 million shares beating the average volume of 14.97 million.

Its shares were trading within the range of $0.0012-$0.0010 while its opening price was $0.0011. Its market capitalization is $2.29 million. Its stock price 52 weeks low was $0.00 and 52 weeks high price was $0.09.

Evcarco Inc (OTC:EVCA) slipped 25.00% to  $0.0003 with the total traded volume of 13.71 million shares having the average volume of 24.78 million.

Its total outstanding shares are 162.12 million shares with the market capitalization of $48,636.00. Its earning per share was $-0.02.

Emisphere Technologies, Inc. (OTC:EMIS) slipped 75.97% to $0.382 with the total traded volume of 8.28 million shares beating the average volume of 0.28 million.

Its shares were trading within the range of $0.34-$0.68 while its opening price was $0.67. Its market capitalization is $23.18 million. Its stock price 52 weeks low was $0.34 and 52 weeks high price was $2.68.

Disclaimer:

The assembled information distributed by epicstocknews.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Epicstocknews.com does expect that investors will buy and sell securities based on information assembled and presented herein. Epicstocknews.com will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information.

Miss the Alert on ACTC? Our Subscribers have been booking gains on stocks like ACTC before the Rest! Check out our Analysis on ACTC
This entry was posted in Trading Briefs and tagged , , , , , , , , , , , . Bookmark the permalink.

One Response to Advanced Cell Together With Geron Start to Reveal Amazing Potential of Stem Cell Therapy – ACTC, SAVW, EVCA, EMIS

  1. says:

    If stem cell treatments were a boxing match, Embryonic stem cell treatments would be the 500 lb Gorilla and Adult stem cell treatments would be the small, unknown underdog. Today, the Gorilla threw in the towel! What would cause the leading Embryonic stem cell Pharmaceutical company with multiple Embryonic stem cell products in development to end all of their Embryonic stem cell programs? What does it mean for patients who were waiting with desperate hope for the benefits of Embryonic stem cells?

Leave a Reply

Your email address will not be published. Required fields are marked *

*


*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>